Genentech became a member of the Roche Group in March of 2009. … Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development operates as a separate business unit within Roche.

Did Roche buy Genentech?

Roche Holding’s agreement on Thursday to acquire full ownership of Genentech for $46.8 billion is the third big drug industry merger this year.

Why did Roche buy Genentech?

On March 12, 2009, Roche announced a $46.8 billion deal to buy South San Francisco, Calif. -based Genentech. … Roche realized that it needed more than just Genentech’s drugs; the firm also wanted to inject the biotech firm’s DNA into its corporate culture.